Proteinuria Treatment Market Forecast and Segments, 2016-2026
American Diabetic Association stated that people with high blood pressure and diabetes are at high risk for developing proteinuria. Thus, increase in diabetic and hypertensive patients worldwide are the main driving factors for the growth of proteinuria treatment market.
American Diabetic Association stated that people with high blood pressure and diabetes are at high risk for developing proteinuria. Thus, increase in diabetic and hypertensive patients worldwide are the main driving factors for the growth of proteinuria treatment market.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Proteinuria</strong><br />
<strong>Treatment</strong><br />
<strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> <strong>Forecast</strong>,<br />
<strong>2016</strong>– <strong>2026</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <strong>and</strong> consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We<br />
combine our knowledge <strong>and</strong> learning from every corner of the world to distill it to one thing – the perfect solution for our<br />
client.<br />
Research<br />
Sector Coverage<br />
Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
• Automotive <strong>and</strong> Transportation<br />
• Chemicals & Materials<br />
• Electronics, Semiconductor, <strong>and</strong> ICT • Food <strong>and</strong> Beverages<br />
• Retail <strong>and</strong> Consumer Products<br />
• Services <strong>and</strong> Utilities<br />
• Industrial Automation <strong>and</strong> Equipment • Energy, Mining, Oil, <strong>and</strong><br />
• Healthcare, Pharmaceuticals & Medical Devices Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
<strong>Proteinuria</strong> is also called as albuminuria is a condition in which urine contains abnormal<br />
(excessive) amount of protein. It is a disease which results from damage within the kidneys. The<br />
kidney performs filtration of waste, minerals <strong>and</strong> fluids from the blood to the urine. When<br />
kidneys do not perform filtration properly that results an abnormal (excessive) amount of<br />
proteins (albumin <strong>and</strong> globulin) excrete through the urine. Sign <strong>and</strong> symptom of proteinuria<br />
includes edema present in face, arms, h<strong>and</strong>s, abdomen <strong>and</strong> hypertension with foamy urine. Risk<br />
factors for proteinuria includes, diabetes <strong>and</strong> hypertension (high blood pressure) mostly <strong>and</strong><br />
sometimes obesity <strong>and</strong> age over 65.<br />
American Diabetic Association stated that people with high blood pressure <strong>and</strong> diabetes are at<br />
high risk for developing proteinuria. Thus, increase in diabetic <strong>and</strong> hypertensive patients<br />
worldwide are the main driving factors for the growth of proteinuria treatment market. Kidney<br />
disease often has no early symptoms. Hence, lack of awareness among people about proteinuria<br />
is expected to restrain the growth of global proteinuria treatment market.<br />
<strong>Proteinuria</strong> <strong>Treatment</strong> <strong>Market</strong>: Drivers <strong>and</strong> Restraints<br />
Types of proteinuria includes Transient <strong>and</strong> Orthostatic proteinuria. <strong>Proteinuria</strong> can be caused by<br />
diseases not involving the kidneys, such as multiple myeloma, a cancer of the plasma cells in the<br />
bone marrow.
Report Description<br />
In diabetes, the main causes of proteinuria are high blood glucose levels over a period of years.<br />
Pre-eclampsia, a condition which can affect pregnant women, includes very high blood pressure<br />
<strong>and</strong> is another potential cause of protein in the urine.<br />
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-<br />
1486<br />
<strong>Proteinuria</strong> <strong>Treatment</strong> <strong>Market</strong>: Segmentation<br />
<strong>Proteinuria</strong> treatment market can be segmented on the basis of drug type, distribution channel<br />
<strong>and</strong> geography.<br />
Based on drug type, proteinuria treatment market can be segmented as follows:<br />
• ACE inhibitors (angiotensin-converting enzyme inhibitors)<br />
• ARBs (angiotensin receptor blockers)<br />
• DPP (dipeptidyl peptidase) IV inhibitors<br />
Based on distribution channel, proteinuria treatment market can be segmented as<br />
follows:<br />
• Hospitals including hospital pharmacies<br />
• Clinics<br />
• Retail Pharmacies
Report Description<br />
<strong>Proteinuria</strong> <strong>Treatment</strong> <strong>Market</strong>: Overview<br />
<strong>Proteinuria</strong> can be diagnosed by urine albumin to creatinine ratio (UACR) test, glomerular<br />
filtration rate (GFR) test, renal ultrasound scan, <strong>and</strong> kidney biopsy test. Since proteinuria is a<br />
symptom <strong>and</strong> not a disease itself, medical care focuses on treating the underlying condition,<br />
such as normalizing blood pressure in people with hypertension or controlling blood sugar levels<br />
in those with diabetes. However, drugs are even prescribed for people with diabetes <strong>and</strong> high<br />
blood pressure.<br />
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1486<br />
<strong>Proteinuria</strong> <strong>Treatment</strong> <strong>Market</strong>: Region-wise Outlook<br />
Region wise, the global proteinuria treatment marketis classified into regions namely, North<br />
America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East <strong>and</strong><br />
Africa. North America dominates the global market for proteinuria treatment due to high<br />
prevalence rate of diabetes <strong>and</strong> hypertension among North American population. Moreover,<br />
technological advancements in diagnostic test further accentuates the market growth in this<br />
region. Europe holds the second position in proteinuria treatment owing to its large geriatric<br />
population base (people above 65 years of age).
Report Description<br />
Asia-pacific holds the third <strong>and</strong> fourth position in the global proteinuria treatment market due<br />
to lack of sufficient healthcare facilities (diagnostic test).<br />
<strong>Proteinuria</strong> <strong>Treatment</strong> <strong>Market</strong>: Key Players<br />
Some of the key players contributing to the global proteinuria treatment market includes Eli Lilly<br />
And Company, Bristol-Myers Squibb, Merck & Co, Inc., AstraZeneca Plc., Reddys Lab, <strong>and</strong><br />
Novartis AG.
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For other queries contact:<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language